Werner Sean 4
4 · BIOLIFE SOLUTIONS INC · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Werner Sean
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-03-03$25.46/sh−136$3,463→ 4,953 total - Sale
Common Stock
2025-03-04$24.03/sh−88$2,115→ 4,865 total
Footnotes (2)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
- [F2]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.